SmallCapVoice.com announced today that a new audio interview with SANUWAVE Health, Inc. (SNWV) is now available. The interview can be heard at http://smallcapvoice.com/blog/4-9-13-smallcapvoice-interview-with-sanuwave-health-inc-snwv
.
Joseph Chiarelli, Chief Executive Officer of SANUWAVE, called into SmallCapVoice.com to go over the business model, market, recent news for company, and the goals for SNWV in 2013. SANUWAVE Health, Inc. has recently initiated a U.S. pivotal clinical trial utilizing its dermaPACE® device in the treatment of diabetic foot ulcers. The trial is expected to enroll a minimum of 90 patients at 20 sites. The company estimates completing the trial and submitting a PMA application for dermaPACE in late 2014.
Let us hear your thoughts below: